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MAJOR ARTICLE

Speciﬁc Behaviors Predict Staphylococcus aureus
Colonization and Skin and Soft Tissue Infections
Among Human Immunodeﬁciency VirusInfected Persons
Nancy F. Crum-Cianﬂone,1,3 Xun Wang,1,4 Amy Weintrob,1,5 Tahaniyat Lalani,1,6 Mary Bavaro,1,3 Jason F. Okulicz,1
Katrin Mende,1,4 Michael Ellis,2 and Brian K. Agan1,4
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Maryland; 5Infectious Disease Clinic, Walter Reed Army Medical Center, Washington, District of Columbia; and 6Infectious Disease Clinic, Naval Medical
Center Portsmouth, Virginia
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Background. Few data exist on the incidence and risk factors of Staphylococcus aureus colonization and skin and
soft tissue infections (SSTIs) among patients infected with human immunodeﬁciency virus (HIV).
Methods. Over a 2-year period, we prospectively evaluated adults infected with HIV for incident S aureus colonization at 5 body sites and SSTIs. Cox proportional hazard models using time-updated covariates were performed.
Results. Three hundred twenty-two participants had a median age of 42 years (interquartile range, 32–49), an
HIV duration of 9.4 years (2.7–17.4), and 58% were on highly active antiretroviral therapy (HAART). Overall, 102
patients (32%) became colonized with S aureus with an incidence rate of 20.6 (95% conﬁdence interval [CI], 16.8–
25.0) per 100 person-years [PYs]. Predictors of colonization in the ﬁnal multivariable model included illicit drug use
(hazard ratios [HR], 4.26; 95% CI, 1.33–13.69) and public gym use (HR 1.66, 95% CI, 1.04–2.66), whereas antibacterial soap use was protective (HR, 0.50; 95% CI, 0.32–0.78). In a separate model, perigenital colonization was associated with recent syphilis infection (HR, 4.63; 95% CI, 1.01–21.42). Fifteen percent of participants developed an
SSTI (incidence rate of 9.4 cases [95% CI, 6.8–12.7] per 100 PYs). Risk factors for an SSTI included incident S aureus
colonization (HR 2.52; 95% CI, 1.35–4.69), public shower use (HR, 2.59; 95% CI, 1.48–4.56), and hospitalization (HR
3.54; 95% CI, 1.67–7.53). The perigenital location for S aureus colonization was predictive of SSTIs. Human immunodeﬁciency virus-related factors (CD4 count, HIV RNA level, and HAART) were not associated with colonization
or SSTIs.
Conclusions. Speciﬁc behaviors, but not HIV-related factors, are predictors of colonization and SSTIs. Behavioral modiﬁcations may be the most important strategies in preventing S aureus colonization and SSTIs among persons infected with HIV.
Keywords. behaviors; colonization; HIV; human immunodeﬁciency virus; MRSA; risk factors; skin and soft
tissue infections; Staphylococcus aureus.
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Staphylococcus aureus is the leading cause of skin and
soft tissue infections (SSTIs) [1]. Persons infected with
the human immunodeﬁciency virus (HIV) are at increased risk for several conditions including both S aureus colonization and infections [2–7]. Studies have
shown that the incidence of S aureus infections is 6to 18-fold higher among HIV-infected compared with
HIV-uninfected persons [6, 8].
Although the precise reason for this increased risk
is unclear, proposed reasons have included immune
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suppression, comorbid conditions, and certain lifestyle behaviors such as illicit drug use and high-risk sexual behaviors [9].
Studies before the advent of highly active antiretroviral therapy
(HAART) largely attributed the increased risk to immunosuppression [3, 10, 11]; however, studies during the HAART era
have shown that antiretroviral medication use and/or CD4
cell counts are often not associated with S aureus infections [9].
Furthermore, despite the availability of HAART in the developed world, persons infected with HIV continue to have elevated incidence rates of S aureus infections [6, 8], suggesting that
factors beyond immunosuppression, such as speciﬁc behaviors
(eg, drug use), may be the most important risk factors.
Additional data are needed to deﬁne the incidence rates and
contemporary risk factors for staphylococcal colonization and
SSTIs among persons infected with HIV. Because many prior
studies have focused on cross-sectional or retrospective data [5,
12–18],intravenous drug-using populations [14],or speciﬁcally on
methicillin-resistant S aureus (MRSA) [7, 19–22], a prospective
study of staphylococcal (both methicillin-susceptible S aureus
[MSSA] and MRSA) colonization among persons infected with
HIV is needed. Furthermore, because S aureus colonization signiﬁcantly increases the risk for subsequent infections [2, 3, 10, 23–
25], data evaluating colonization at multiple body sites beyond
the nares are warranted because such carriage may be important
in the development of SSTIs [19]. Therefore, we used a large, prospective study of adults infected with HIV to determine the incidence of and risk factors for staphylococcal colonization at 5
body sites as well as the subsequent development of SSTIs.
METHODS
Study Population

A prospective study was designed to evaluate staphylococcal
colonization among HIV-infected adults during a 2-year period. The primary outcome was efﬁcacy of a decolonization strategy in reducing carriage among those who screened positive for
MRSA carriage as previously reported [26]. The study also
aimed to determine the incidence of and risk factors for staphylococcal (MRSA and MSSA) colonization and SSTIs over time
among those who initially screened negative at baseline.
We evaluated 516 adults infected with HIV for incident
S aureus colonization at 5 body sites (ie, bilateral nares, pharynx, bilateral axilla, bilateral groin areas, and perirectal area).
After excluding those with S aureus colonization at the baseline
visit (n = 161) or those lost to follow-up (n = 33), 322 participants were prospectively observed over a 2-year period for incident colonization. We also evaluated participants with no prior
history of SSTIs (n = 293) for the outcome of incident SSTIs.
Participants were enrolled between May 2007 and May 2010
with study completion in 2012. Clinical sites were located in
geographically diverse locations across the United States and included the Naval Medical Center San Diego (San Diego, CA),
2
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Walter Reed Army Medical Center (Washington DC), and
Naval Medical Center Portsmouth (Portsmouth, VA).
Study Procedures

After the baseline visit to assess for prevalent S aureus colonization, participants who screened negative for S aureus at all body
sites were observed every 6 months over a 2-year period. During
each study visit, participants underwent screening for S aureus
carriage at 5 body sites. Because prior studies demonstrated the
importance of extranasal colonization [27–30], perirectal and
throat cultures were collected along with the 3 standard sites
(nares, axilla, and groin). Swabs (n = 5; BBL CultureSwab Plus;
Becton Dickinson and Company, Sparks Glencoe, MD) were
collected by a physician, and the presence of S aureus was determined by College of American Pathologists-accredited laboratories at each clinical site using standard microbiological methods
[31]. We included both MSSA and MRSA colonization in our
study outcome, and we did not speciﬁcally evaluate MRSA colonization given its low incidence rate. Skin and soft tissue infections were recorded at each study visit using detailed questions
by research study coordinators who inquired about the occurrence of cellulitis, abscess, carbuncles, furuncles, pustules, or folliculitis during the past 6 months. Patients underwent a physical
examination at each study visit including a skin examination.
Any active SSTI with a drainable collection was cultured. Participants were also educated regarding SSTIs and instructed to present to clinic for evaluation with any signs of an SSTI, including
during times between scheduled study visits.
During each study visit, participants completed a questionnaire assessing several factors of interest including demographics
and speciﬁc behaviors over the past 6 months. Behaviors assessed
included use of antimicrobial soap, drug use (illicit drugs, alcohol, and tobacco), use of public gyms and showers, contact
sports, sharing personal items (eg, towels, razors), shaving practices, receipt of a tattoo, and sexual activity including condom use
and number of partners. We also assessed number of household
contacts and pet ownership during each 6-month period.
Research coordinators collected data from the medical records
during every 6-month visit regarding HIV-speciﬁc information
including HIV duration (time from the ﬁrst HIV-positive test
until study enrollment), diagnosis of acquired immune deﬁciency
syndrome (AIDS), CD4 cell count, HIV RNA level, and use
of HAART (deﬁned as the use of 3 or more full-dose antiretroviral medications). In addition, medical conditions (eg, cancer,
diabetes, liver disease, kidney disease, skin conditions, and recent sexually transmitted infections), medication use (including
trimethoprim-sulfamethoxazole and therapies requiring injections), and healthcare encounters (emergency department visits
and hospitalizations) were abstracted from the medical records
and entered on standard case report forms.
All participants provided voluntary written informed consent.
The study was approved by the governing military institutional

review boards at each clinical site and conducted in accordance
with the principles of the Declaration of Helsinki and standards
of Good Clinical Practice (as deﬁned by the International Conference on Harmonization).
Statistical Methods

Descriptive statistics were performed evaluating the baseline
characteristics of the study population and presented as numbers
(percentages) and medians (interquartile ranges [IQRs]) for categorical and continuous variables, respectively. Participants were
observed until the ﬁrst occurrence of S aureus colonization or
censor; those without colonization were censored at last study
visit. Incidence rates were calculated as the number of events divided by person-years (PYs) of follow-up.
At each 6-month visit, colonization status and exposures of interest were assessed and used in the models as time-updated variables. Univariable and multivariable Cox proportional hazard
models with time-updated covariates assessed the predictors of
S aureus colonization. The ﬁnal multivariable model was created
using a stepwise approach and included only variables that were
statistically signiﬁcant. All statistical tests were 2 sided, and
P value < .05 was considered statistically signiﬁcant. Hazard ratios
(HR) are reported with 95% conﬁdence intervals (CIs). Likewise,
a separate model was created for the outcome of incident SSTIs
using the same methodology. All statistical analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC).

and if perigenital cultures had not been performed, 13% of all
colonization would have been missed. Exclusive throat colonization occurred in 10% of those colonized, whereas exclusive
axilla positivity was found in only 3%. The overlap of colonization (nares, throat, and perigenital) is shown in Figure 1. Regarding the type of S aureus, colonization was MSSA in 89
cases, MRSA in 10 cases, and both MSSA and MRSA in 3 cases.
In the univariable models, S aureus colonization was predicted by recent (in the last 6 months) illicit drug use, with borderline signiﬁcant associations (P ≤ .10) with public gym use,
having a skin condition, and hospitalization. Self-reported antibacterial soap use was associated with a reduced risk (Table 2).
In the ﬁnal multivariable model, predictors of S aureus colonization included illicit drug use (HR, 4.26; 95% CI, 1.33–13.69)
and public gym use (HR, 1.66; 95% CI, 1.04–2.66). In addition,
antibacterial soap use was found to be protective of colonization
(HR, 0.50; 95% CI, 0.32–0.78) (data not shown).
Because incident colonization at the perigenital location may
have unique risk factors, we performed a separate model for colonization at this speciﬁc site. In the ﬁnal multivariable model,
perigenital S aureus colonization was associated with recent
syphilis (HR, 4.63; 95% CI, 1.01–21.42), public shower use
(HR, 4.33; 95% CI, 1.35–13.90), and hospitalization (HR,
5.11; 95% CI, 1.35–19.35). No relationships were noted between
perigenital S aureus colonization and self-reported sexual activity or self-reported condom use (data not shown).

RESULTS

Incidence of and Risk Factors for Skin and Soft Tissue
Infections

Study Population

Among the study population with no history of SSTIs at baseline (n = 293), 15% developed an SSTI during the study period
(incidence rate of 9.4 cases [95% CI, 6.8–12.7] per 100 PYs).
Culture specimens were obtained from 15 of 43 (35%) of
SSTI cases, yielding S aureus in 4 cases (27% of infections
with a culture). Other organisms identiﬁed included betahemolytic streptococci (4) and Gram-negative bacilli (3),
whereas the remainder showed normal skin ﬂora (eg, coagulase-negative staphylococci). Skin and soft tissue infections included furuncles or pustules in 20 cases, abscesses in 5 cases,
cellulitis in 5 cases, folliculitis in 3 cases, carbuncles in 2
cases, and other localized skin infections in 8 cases. The location
of the infection was most commonly on the trunk (n = 14), followed by upper extremity (n = 11), perigenital area (n = 8),
lower extremity (n = 8), and head/neck (n = 8); some infections
involved multiple sites.
Risk factors for developing an SSTI in the time-updated univariable models are shown in Table 3. In the ﬁnal multivariable
model, incident S aureus colonization (HR, 2.52; 95% CI, 1.35–
4.69), public shower use (HR, 2.59; 95% CI, 1.48–4.56), and
hospitalization in the last 6 months (HR, 3.54; 95% CI, 1.67–
7.53) were predictors for SSTIs. HIV-related factors (history
of AIDS, CD4 cell count, HIV RNA level, and HAART use)

Three hundred twenty-two participants were studied with a median age of 42 years (IQR, 32–49) and 93% were male. The median CD4 count was 525 cells/mm3 (IQR, 404–716), 57% had an
undetectable HIV RNA level (<50 copies/mL), and 58% were receiving HAART. Other characteristics of the study population are
shown in Table 1.
Incidence of and Risk Factors for Staphylococcus aureus
Colonization

Overall, 102 (32%) participants became colonized with S aureus
during the study period for an incidence rate of 20.6 (95% CI,
16.8–25.0) per 100 PYs. Among those colonized, the most common site of colonization was the nares in 72.5% (n = 74), followed by the throat (14.7%, n = 15), groin (13.7%, n = 14),
perirectal area (13.7%, n = 14), and axilla (9.8%, n = 10). Some
patients had multiple sites of incident colonization with 87 participants having a single site of colonization, whereas 9 had 2
sites, 2 had 3 sites, and 4 had 4 sites; no patient had colonization
at all 5 body sites.
A nares-only culture survey would have missed 27.4% of
S aureus colonization in the study. Overall, 23% of colonized
participants had perigenital (groin and/or perirectal) carriage,
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Table 1.

Baseline Descriptive Characteristics Among HIV-Infected Adults by Incident Staphylococcus aureus Colonization

Variablea

Total N (%)

Total

322

MRSA/MSSA Colonization N (%)
102

No MRSA/MSSA Colonization N (%)
220

Demographics
Age, yearsb

42 (32–49)

42 (35–49)

42 (31–50)

Race
Caucasian

175 (54.3)

52 (51.0)

African-American

126 (39.1)

41 (40.2)

85 (38.6)

21 (6.5)

9 (8.8)

12 (5.5)

298 (92.5)

95 (93.1)

203 (92.3)

150 (46.6)

37 (36.3)

113 (51.4)

10 (3.1)

2 (2.0)

8 (3.6)

229 (71.1)

76 (74.5)

153 (69.5)

Other
Gender, male

123 (55.9)

Behaviors
Antibacterial soap use
Illicit drug use
Alcohol use
Tobacco use

96 (29.8)

34 (33.3)

62 (28.2)

Public gym use

188 (58.4)

64 (62.7)

124 (56.4)

Public shower use

141 (43.8)

48 (47.1)

93 (42.3)

Plays football

19 (5.9)

6 (5.9)

13 (5.9)

Plays soccer

15 (4.7)

4 (3.9)

11 (5.0)

Shares personal items

11 (3.4)

2 (2.0)

9 (4.1)

151 (46.9)

47 (46.1)

104 (47.3)

Body shaving
Tattoo

60 (18.6)

22 (21.6)

38 (17.3)

180 (55.9)

58 (56.9)

122 (55.5)

0

117 (36.3)

36 (35.3)

81 (36.8)

1

98 (30.4)

31 (30.4)

67 (30.5)

≥2

65 (20.2)

17 (16.7)

48 (21.8)

Lives alone

119 (37.0)

30 (29.4)

89 (40.5)

Owns a pet

146 (45.3)

51 (50.0)

95 (43.2)

Sexually active, yes
Number of sexual partners

HIV-related factors
Duration of HIV, yearsb

9.4 (2.7–17.4)

AIDS diagnosis

72 (22.4)

CD4 countb, cells/mm3

525 (404–716)

10.3 (2.4–18.2)
25 (24.5)
521 (373–711)

8.6 (3.0–17.1)
47 (21.4)
528 (414–719)

CD4 count, cells/mm3
<350

58 (18.0)

22 (21.6)

36 (16.4)

≥350

264 (82.0)

80 (78.4)

184 (83.6)

Viral load, undetectable <50 copies/mL

183 (56.8)

56 (54.9)

127 (57.7)

Current HAART use

185 (57.5)

56 (54.9)

129 (58.6)

Cancer

13 (4.0)

0 (0.0)

13 (5.9)

Diabetes

17 (5.3)

3 (2.9)

14 (6.4)

8 (2.5)

1 (1.0)

7 (3.2)

Liver disease

13 (4.0)

3 (2.9)

10 (4.5)

Skin disease

34 (10.6)

14 (13.7)

20 (9.1)

Chlamydia

35 (10.9)

13 (12.7)

22 (10.0)

Gonorrhea

87 (27.0)

28 (27.5)

59 (26.8)

Syphilis

74 (23.0)

19 (18.6)

55 (25.0)

TMP-SMX

25 (7.8)

9 (8.8)

16 (7.3)

Injectable medication

13 (4.0)

4 (3.9)

9 (4.1)

ED visit

96 (29.8)

24 (23.5)

72 (32.7)

Hospitalized

49 (15.2)

12 (11.8)

37 (16.8)

Medical Conditions

Kidney disease

Medication Use

Healthcare Encounters

Abbreviations: ED, emergency department; HAART, highly active antiretroviral therapy; HIV, human immunodeficiency virus; MRSA, methicillin-resistant S aureus;
MSSA, methicillin-susceptible S aureus; TMP-SMX, trimethoprim-sulfamethoxazole.
a
Factors were ascertained within the last 6 months before each study visit. All data represent n = 322, except there were missing data for the following variables:
antibacterial soap use (n = 3), illicit drug use (3), alcohol use (3), tobacco (2), public gym (4), public shower (2), football (3), soccer (2), shared personal items (10),
shaving (5), tattoo (1), sexually active (21), number of sexual partners (42), lives alone (2), owns a pet (3), HAART use (9), cancer (3), diabetes (4), kidney disease (5),
liver disease (7), skin disease (3), chlamydia (3), gonorrhea (2), syphilis (4), TMP-SMX use (3), injection drug use (4), ED visit (7), and recent hospitalization (2).
b
Median, interquartile range.

4

•

OFID

•

Crum-Cianﬂone et al

Table 2. Univariable Risk Factors for Staphylococcus aureus
Colonization
Hazard Ratio
(95% CI)

Variablea

P Value

Demographics
Age, per 1 yr

1.00 (0.98, 1.02)

.81

Race
Caucasian

1.00

.84

African-American

1.04 (0.69, 1.57)

.20

Other

1.60 (0.79, 3.25)

Gender, male

1.07 (0.50, 2.31)

.86

Duration of HIV, per 1 yr

1.00 (0.98, 1.03)

.99

AIDS diagnosis

1.10 (0.70, 1.74)

.67

<350

1.00

.86

≥350

1.05 (0.62, 1.76)

HIV-related factors

CD4 count, cells/mm3

Figure 1. Venn diagram of the overlap of incident Staphylococcus aureus colonization at various body sites. Each circle size is proportional to the
number colonized at each anatomic site. Perigenital is groin and/or perirectal colonization. The axilla site was omitted for simplicity.

were not predictive. In a separate multivariate model, we evaluated if incident S aureus colonization at the perigenital site was a
predictor of subsequent development of an SSTI and found a
signiﬁcant relationship (HR, 3.95; 95% CI, 1.94–8.03).
DISCUSSION
Adults infected with HIV continue to have a high incidence of
S aureus colonization and SSTIs during the HAART era. This
study found that speciﬁc behaviors were signiﬁcant predictors
for S aureus colonization, and that incident colonization, particularly in the perigenital area, increased the risk for subsequent
SSTIs. More importantly, HIV-related factors such as level of
immunosuppression and HAART use were not signiﬁcantly associated with either colonization or SSTIs. These data may be
important for understanding the continued increased risk of S
aureus colonization and SSTIs among adults infected with HIV
and for development of preventive strategies.
The incidence rate of S aureus colonization of 20 per 100 PYs
in our HIV cohort is higher than described among HIV-negative
persons [32]. Before the HAART era, the increased rates of S aureus colonization, and subsequent infections, were mainly attributed to immunosuppression and frequent healthcare encounters
[3, 10, 11]. However, despite the availability of effective HAART,
rates of S aureus colonization have remained elevated.
Predictors for S aureus colonization in our study included
speciﬁc behaviors. These data suggest that the increased colonization rates during the HAART era may no longer be largely

Viral load, undetectable <50 copies/mL

1.07 (0.72, 1.61)

.73

Current HAART use

1.03 (0.63, 1.66)

.91

Illicit drug use

3.75 (1.37, 10.26)

.01*

Alcohol use

0.98 (0.64, 1.51)

.94

Tobacco use

1.08 (0.69, 1.69)

.73

Lives alone

1.00 (0.65, 1.52)

.98

Owns a pet

1.14 (0.76, 1.72)

.54

Public gym use

1.50 (0.98, 2.29)

.06**

Public shower use

1.07 (0.71, 1.61)

.76

Plays football

0.74 (0.27, 2.02)

.56

Plays soccer

1.13 (0.42, 3.09)

.81

Sexually active, yes

0.86 (0.57, 1.31)

.48

Behaviors

Number of sexual partners
0

1.00

.99

1

1.00 (0.62, 1.61)

.95

≥2

1.02 (0.56, 1.85)

Antibacterial soap use

0.54 (0.34,0.83)

.01*

Shares towels

1.49 (0.55, 4.08)

.43

Body shaving

1.21 (0.8, 1.82)

.37

Tattoo

1.67 (0.8, 3.5)

.17

Cancer

2.35 (0.74, 7.43)

.15

Diabetes

1.59 (0.50, 5.03)

.43

Medical Conditions

Kidney disease
Liver disease

1.20 (0.30, 4.89)

.80

Skin disease

2.00 (0.87, 4.58)

.10

Sexually transmitted infections
Chlamydia

1.53 (0.21, 10.98)

.68

Gonorrhea

1.41 (0.35, 5.73)

.64

Syphilis

1.04 (0.33, 3.28)

.95

Medication Use
TMP-SMX

0.67 (0.25, 1.84)

.44

Injectable medication

0.80 (0.29, 2.17)

.66

Healthcare Encounters
ED visit

1.11 (0.65, 1.91)

.70

Hospitalized

1.75 (0.91, 3.39)

.10

Abbreviations: AIDS, acquired immune deficiency syndrome; CI, confidence
interval; ED, emergency department; HAART, highly active antiretroviral therapy;
HIV, human immunodeficiency virus; TMP-SMX, trimethoprim-sulfamethoxazole.
a
Factors were ascertained within the last 6 months before each study visit.
* P < .05.
** P < .10.
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Table 3.

Univariable Risk Factors for SSTIs
Hazard Ratio
(95% CI)

Variablea
Staphylococcus aureus colonization

P Value

2.91 (1.59, 5.34)

.001*

0.97 (0.94, 0.99)

.02*

Demographics
Age, per 1 yr
Race
Caucasian

1.00

.13

African-American

0.61 (0.32, 1.16)

.33

Other

0.37 (0.05, 2.75)

Gender, male

1.58 (0.38, 6.51)

.53

Duration of HIV, per 1 yr

0.92 (0.88, 0.97)

<.001*

AIDS diagnosis

0.49 (0.19, 1.24)

.13

<350

1.00

.27

≥350

0.67 (0.33, 1.37)

HIV-related factors

CD4 count, cells/mm3

Viral load, undetectable <50 copies/mL

1.61 (0.88, 2.92)

.12

Current HAART use

0.66 (0.33, 1.32)

.24

Behaviors
Illicit drug use

5.61 (1.71, 18.36)

.004*

Alcohol use

0.93 (0.5, 1.74)

.81

Tobacco use

1.77 (0.96, 3.26)

.07**

Lives alone

1.01 (0.54, 1.87)

.99

Owns a pet

1.68 (0.9, 3.11)

.10

Public gym use

2.12 (1.09, 4.19)

.03*

Public shower use

2.72 (1.45, 5.10)

.002*

Plays football

0.41 (0.06, 3.00)

.38

Sexually active, yes

1.59 (0.82, 3.10)

.17

Number of sexual partners
0

1.00

1

0.50 (0.22, 1.12)

.09**

≥2

0.59 (0.26, 1.34)

.21

Antibacterial soap use

0.72 (0.37, 1.39)

.33

Shares towels

0.72 (0.1, 5.24)

.75

Body shaving

1.41 (0.78, 2.57)

.26

Tattoo

3.07 (1.29, 7.32)

.01*

Kidney disease

1.89 (0.26, 13.85)

.53

Liver disease

1.39 (0.19, 10.12)

.75

Skin disease

1.46 (0.35, 6.02)

.61

1.02 (0.14, 7.46)

.99

Medical Conditionsb

Sexually transmitted infectionsb
Syphilis
Medication Use
TMP-SMX

1.25 (0.38, 4.08)

.71

Injectable medication

4.14 (1.91, 8.95)

<.001*

ED visit

2.28 (1.16, 4.47)

.02*

Hospitalized

3.17 (1.40, 7.16)

.01*

Healthcare Encounters

Abbreviations: AIDS, acquired immune deficiency syndrome; CI, confidence
interval; ED, emergency department; HAART, highly active antiretroviral
therapy; HIV, human immunodeficiency virus; SSTIs, skin and soft tissue
infections; TMP-SMX, trimethoprim-sulfamethoxazole.
a

Factors were ascertained within the last 6 months before each study visit.

b

Unable to examine diabetes, cancer, gonorrhea, or chlamydia given no diagnosis among the SSTI cases.
* P < .05.
** P < .10.
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attributed to immunosuppression [2, 19] but rather to speciﬁc
behaviors among persons infected with HIV. In our cohort, illicit drug and public gym use were signiﬁcantly associated with
incident S aureus colonization; these speciﬁc behaviors may
lead to exposure to S aureus via person-to-person contact or fomites such as shared drug paraphernalia or exercise equipment.
We also found that patients with HIV who reported the use of
antibacterial soap had a reduced risk for S aureus colonization.
Whether this was directly related to the use of these products or
indirectly related as a marker of improved hygiene is unknown;
a previous study showed low rates of showering was associated
with staphylococcal colonization and infection [33].
When examining the speciﬁc body site of S aureus colonization, we found that incident colonization in the perigenital area
was associated with a recent diagnosis of syphilis. These data
suggest the possibility of S aureus transmission during sexual
activity. Prior cross-sectional studies have found associations
between some sexual behaviors (eg, STIs, condom use) and
MRSA carriage [16, 27]; our data conﬁrms this relationship
using prospective data. We did not ﬁnd an association with
self-reported sexual risk factors; however, this could be related
to underreporting of these behaviors and/or missing data for
these speciﬁc questions.
The current study highlights the value of 5-site testing for
detection of incident S aureus colonization including the importance of throat and perigenital sites—adding these sites increased detection by 29%. Our study found low rates of incident
MRSA colonization. Previous data suggest that MRSA may be
declining in persons infected with HIV [34–36], similar to
that seen in the general population [37]. Because both MSSA
and MRSA carriage are associated with subsequent infections
[10], these data are important in understanding S aureus in
this vulnerable population.
Skin and soft tissue infections occurred in 15% of our HIV
cohort during the 2-year study period with an incidence rate
of 9.4 cases per 100 PYs, higher than estimates in the general
population (3.2–4.9/100 PYs) [38, 39] but similar to a prior
study among persons infected with HIV (11.7/100 PYs) [19].
Because some SSTIs in our study did not have purulent collections and hence lacked culture data, their precise etiology was
unknown; however, it is likely that several SSTIs were due to
S aureus since colonization with this organism in the prior 6
months was signiﬁcantly associated with the development of
SSTIs. This also concurs with prior publications showing a relationship between S aureus colonization and subsequent infections [2, 3, 10, 11, 19, 23–25, 40]. Our study is unique because we
evaluated the speciﬁc location of S aureus colonization and subsequent development of SSTIs. We found that perigenital colonization was related to subsequent infection, a ﬁnding concurrent
with a recent study among men who have sex with men that
found that perianal MRSA colonization was a risk factor for
SSTIs [19].

In addition to incident S aureus colonization, our study also
found that speciﬁc behaviors including public shower use in the
past 6 months was associated with SSTIs in multivariable models. Predictors of SSTIs also included factors related to breaches
in skin integrity that may allow S aureus access to deeper tissues
including recent hospitalization, perhaps due to concurrent
placement of intravenous lines or surgical procedures compromising skin integrity.
The ﬁndings of this study may have clinical implications. For
example, many HIV patients inquire about the pathogenesis of
S aureus colonization or infection, and these data provide avenues for education and potential preventive guidance. Prospective studies on interventions to modify behavioral factors are
needed to determine whether these speciﬁc strategies could
limit future S aureus transmission and infection.
Our study had several limitations. We were unable to specifically examine incident MRSA colonization or SSTIs due to the
low numbers of events; however, our data mirror studies showing a decline in MRSA among patients infected with HIV [34–
36]. The objective of the current study was incident colonization
and SSTIs; future studies may examine other outcomes such as
colonization persistence and SSTI recurrence. Our study was
performed among military members and veterans who were
mostly men; hence, study ﬁndings may not be generalizable
to women or other HIV populations. Furthermore, few participants had low CD4 counts (<200 cells/mm3) or were receiving
trimethoprim-sulfamethoxazole prophylaxis [4, 11, 15, 20, 21];
however, in the HAART era these potential factors may be
less common. Our study did not collect data on HIV acquisition
risk factors due to the US military’s policy, “don’t ask, don’t
tell,” which was in effect at the time of study initiation; other
studies have shown that most HIV infections in the US military
are related to sexual activities (with at least 50% reporting homosexual risk factors), with very low rates due to intravenous
drug use [41]. Molecular characterization of isolates was not
available in our study. Finally, some data was based on selfreport; however, when possible we used medical records to verify
information including medical conditions and STIs.
Strengths include being one of the largest and longest prospective studies among HIV-infected persons providing contemporary data on S aureus colonization and SSTI incidence rates
and risk factors. Furthermore, we assessed colonization using 5
different body locations. We evaluated the temporal associations
between potential risk factors and subsequent incident colonization and SSTIs using time-updated 6-month intervals of data collection over a 2-year period. Finally, the study examined a large
number of self-reported and objective factors.
CONCLUSIONS
In summary, persons infected with HIV remain at a higher risk
for several health conditions during the HAART era, including

incident S aureus colonization and SSTIs. Speciﬁc behaviors,
rather than HIV-related factors, were risk factors for S aureus
colonization and SSTIs. Risky sexual behavior as indicated by
recent syphilis infection was associated with perigenital S aureus
colonization, which in turn was associated with incident SSTIs.
In addition, behaviors such as illicit drug use and public gym
use were signiﬁcant risk factors for incident S aureus colonization. These data suggest that behavioral modiﬁcations may be
the most important strategies in preventing S aureus colonization and SSTIs among persons infected with HIV.
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